Forty hospitalized patients with complicated urinary tract infections were treated with gentamicin 240 mg die i.m. or ceftriaxone, a new parenteral cephalosporin, 2 g die i.v. for 7 days.
Ceftriaxone gave good clinical and bacteriological results which were better than those obtained with gentamicin, showing also an appreciable activity in cases of infection due to problematic organisms.
Get full access to this article
View all access options for this article.
References
1.
AngehrnPProbstP J (1981) Antibacterial properties of Ro 13–9904, a long-acting new cephalosporin. Chemotherapy, 27, Suppl 1, 9.
2.
HahnL BernsteinBarclayC AIribarrenM ATraballiC A (1981a) Ceftriaxone, a new parenteral cephalosporin, in the treatment of urinary tract infections. Chemotherapy, 27, Suppl 1, 75.
3.
HahnL BernsteinBarclayACasellasJ MIribarrenM AFarinatiATraballiC A (1981b) Ceftriaxone, a new parenteral cephalosporin: comparative study with gentamicin in severe urinary tract infections. 12th International Congress of Chemotherapy. Firenze-Luglio.
4.
ChauP YNgW SLingJArnoldK (1981) In vitro susceptibility of Salmonella to various antimicrobial agents, including a new cephalosporin, Ro 13–9904. Antimicrobial Agents and Chemotherapy, 19, 8.
5.
Di SilverioFGalfanoGCrinitiPZezzaASecciaM (1979) L'infezione urinaria: importanza e significato dei livelli tissutali degli antibiotici. Boll. Atti Soc. Centro Merid. Urol.14, 101.
6.
FernexMHavasL (1981) Reports on ceftriaxone. Chemotherapy, 27, Suppl 1, 1.
7.
GiamarellouHPoulopoulosVKatsabasAPetrikkosGDaikosG K (1980) Preliminary experience with Ro 13–9904 in gonorrhoea and chronic urinary tract infections. 2nd Mediterranean Congress of Chemotherapy. Nice abstr. 215.
8.
GiamarellouHPoulopoulosBKatsabasAPetrikkosGPapapetropoulouMDaikosG K (1981) Antibacterial activity of Ro 13–9904 and preliminary experience in gonorrhoea and chronic urinary tract infections. Chemotherapy, 27, Suppl 1, 70.
9.
KassE H (1957) Bacteriuria and the diagnosis of infection of the urinary tract. Archives of Internal Medicine100, 709.
10.
Kunin C M (in Nardi e Coll.) (1975). Journal of Urology113, 585.
11.
LottiT (1979) Problemi di terapia medica dell'infezione urinaria dello adulto. Boll. Atti Soc. Centro. Merid. Urol.14, 77.
12.
Lye M (in Nardi e Coll.) (1978). Geriatrics33, 71.
13.
NardiRSavoraniGSartiGRosatiMSalsiA (1981) La terapia della infezioni delle vie urinarie nell'età senile. Recenti Progressi in Medicina70, 181.
14.
PopaGNuriM (1976) Il cefacetrilex nel trattamento delle infezioni urinarie con particolare riferimento al problema dei microrganismi Zeitschr Klin. Ther. Infektionen4, Suppl. 3, 272.
15.
ReinerRWeissUBrombacherULanzPMontavonMFurlenmeierAAngehrnPProbstP J (1980) Ro 13–9904/001 a novel potent and long-acting parenteral cephalosporin. Journal of Antibiotics33, 783.
16.
SeddonMWiseRGilletA PLivingstonR (1980) Pharamacokinetics of Ro 13–9904, a broad spectrum cephalosporin. Antimicrobial Agents and Chemotherapy18, 240.
17.
SeilerWStahelinH BBohniE (1980) Clinical and bacteriological results in urinary tract infections with single dose Ro 13–9904 (Rocephin®). Chemotherapy, 27, Suppl 1, 80.
18.
StoeckelK (1981) Pharmacokinetics of Rocephin®, a highly active new cephalosporin with an exceptionally long biological half-life. Chemotherapy, 27, Suppl 1, 42.
19.
StoeckelKMcNamaraP JBrandtRZieglerW H (1981) Dose-dependent pharmacokinetics of ceftriaxone (Ro 13–9904), a new highly active cephalosporin. Abstracts of the American Society for Clinical Pharmacology and Therapeutics. New Orleans.
20.
ThabautADurosoirJ LSaliouP (1980) Activité comparée in vitro de 8 céfalosporines sur 109 souches de Neisseria gonorrhoeae et 60 souches de Neisseria meningitidis. 2nd Mediterranean Congress of Chemotherapy. Nice, abstr. 376.
21.
WilliamsR JWilliamsJ DFarrelW (1980) Effects of antipseudomonal cephalosporin – like compounds and their sinergy with carbenicillin and aminoglycosides. 20th Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, abstr. 91.
